Correlation Between Blueprint Medicines and Akebia Ther

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Akebia Ther, you can compare the effects of market volatilities on Blueprint Medicines and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Akebia Ther.

Diversification Opportunities for Blueprint Medicines and Akebia Ther

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Blueprint and Akebia is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Akebia Ther go up and down completely randomly.

Pair Corralation between Blueprint Medicines and Akebia Ther

Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 1.06 times more return on investment than Akebia Ther. However, Blueprint Medicines is 1.06 times more volatile than Akebia Ther. It trades about 0.23 of its potential returns per unit of risk. Akebia Ther is currently generating about 0.24 per unit of risk. If you would invest  9,063  in Blueprint Medicines Corp on November 9, 2024 and sell it today you would earn a total of  1,899  from holding Blueprint Medicines Corp or generate 20.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Blueprint Medicines Corp  vs.  Akebia Ther

 Performance 
       Timeline  
Blueprint Medicines Corp 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Blueprint Medicines Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Blueprint Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.
Akebia Ther 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Ther are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Akebia Ther may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Blueprint Medicines and Akebia Ther Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Blueprint Medicines and Akebia Ther

The main advantage of trading using opposite Blueprint Medicines and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.
The idea behind Blueprint Medicines Corp and Akebia Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies